Martin Lipp

1 Patent

• US116677222023

  Antibody That Binds CD269 (BCMA) Suitable for Use in the Treatment of Plasma Cell Diseases Such as Multiple Myeloma and Autoimmune Diseases

  Max-delbrück-centrum Für Molekulare Medizin In Der Helmholtz-gemeinschaft

  0 cites